$MLSS

Milestone Scientific Inc. reported its Q4 2025 earnings, showcasing a significant increase in revenue compared to the previous quarter. The company attributed the growth to strong demand for its dental anesthesia products. Management provided optimistic guidance for the upcoming quarters, anticipating continued adoption of their technology in other medical fields. Additionally, they announced a strategic partnership with a major healthcare provider aimed at expanding distribution. Overall, the outlook is positive, with increased market confidence in Milestone's growth potential.